Future Medicine

SHERPA: White

People

  1. Sabbatini
    Sabbatini
  2. Grisham
    Grisham
  3. Konner
    Konner
  4. O'Cearbhaill
    O'Cearbhaill
  5. Tew
    Tew

Groups

  1. Department of Medicine (6)
  2. GDMT, Medicine (6)
  3. Gynecologic Medicine Service (6)
  4. Gynecology Disease Management Team (6)
  5. Solid Tumor Oncology Division (6)
  6. Hematologic Malignancies, Division of (1)
Search Within
  1. "GDMT, Medicine"
Formats
  1. Journal Article (6)
Groups
  1. Department of Medicine (6)
  2. GDMT, Medicine (6)
  3. Gynecologic Medicine Service (6)
  4. Gynecology Disease Management Team (6)
  5. Solid Tumor Oncology Division (6)
  6. Hematologic Malignancies, Division of (1)
People
  1. Paul Sabbatini (2)
  2. Dmitriy Zamarin (1)
  3. Jason Konner (1)
  4. Rachel Grisham (1)
  5. Roisin O'Cearbhaill (1)
  6. William Tew (1)
Years
  1. 2024 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2012 (1)
  5. 2011 (1)
  6. 2010 (1)
Publications
  1. Future Oncology (3)
  2. Future Microbiology (1)
  3. Immunotherapy (1)
  4. Therapy (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Progression-free survival and safety at 3.5 years of follow-up: Results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – A plain language summary
    Journal Article

    González-Martín, A.; Pothuri, B.; Vergote, I.; Graybill, W.; Lorusso, D.; McCormick, C. C.; Freyer, G.; Backes, F.; Heitz, F.; Redondo, A.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Utilization of tumor genomics in clinical practice: An international survey among ASCO members
    Journal Article

    Barroso-Sousa, R.; Guo, H.; Srivastava, P.; James, T.; Birch, W.; Siu, L. L.; Tew, W. P.; Tolaney, S. M.
    Future Oncology (2019)

    Fulltext@MSK | Save
  • A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer
    Journal Article

    Moore, K. N.; Martin, L. P.; O'Malley, D. M.; Matulonis, U. A.; Konner, J. A.; Vergote, I.; Ponte, J. F.; Birrer, M. J.
    Future Oncology (2018)

    Fulltext@MSK | Save
  • Oncolytic Newcastle disease virus for cancer therapy: Old challenges and new directions
    Journal Article

    Zamarin, D.; Palese, P.
    Future Microbiology (2012)

    Fulltext@MSK | Save
  • Abagovomab: An anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
    Journal Article

    Grisham, R. N.; Berek, J.; Pfisterer, J.; Sabbatini, P.
    Immunotherapy (2011)

    Fulltext@MSK | Save
  • Ovarian cancer in 2010
    Journal Article

    Sabbatini, P.; Pfisterer, J.
    Therapy (2010)

    Fulltext@MSK | Save

    • Future Medicine – authorized name for: